These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 762612)

  • 21. Epidemiology of subacute sclerosing panencephalitis (SSPE). A report of the SSPE registry.
    Jabbour JT; Duenas DA; Sever JL; Krebs HM; Horta-Barbosa L
    JAMA; 1972 May; 220(7):959-62. PubMed ID: 4554467
    [No Abstract]   [Full Text] [Related]  

  • 22. High incidence of subacute sclerosing panencephalitis in south India.
    Saha V; John TJ; Mukundan P; Gnanamuthu C; Prabhakar S; Arjundas G; Sayeed ZA; Kumaresan G; Srinivas K
    Epidemiol Infect; 1990 Feb; 104(1):151-6. PubMed ID: 2307182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children.
    Lucas KM; Sanders RC; Rongap A; Rongap T; Pinai S; Alpers MP
    Epidemiol Infect; 1992 Jun; 108(3):547-53. PubMed ID: 1601084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing character of subacute sclerosing panencephalitis in the United States.
    Dyken PR; Cunningham SC; Ward LC
    Pediatr Neurol; 1989; 5(6):339-41. PubMed ID: 2491742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SSPE: epidemiological and serological features in a series of cases recorded between 1975 and 1984.
    Cernescu C; Cajal N; Popescu-Tismana G
    Virologie; 1985; 36(4):247-54. PubMed ID: 4090270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing epidemiological features of subacute sclerosing panencephalitis.
    Anlar B; Köse G; Gürer Y; Altunbaşak S; Haspolat S; Okan M
    Infection; 2001 Aug; 29(4):192-5. PubMed ID: 11545478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subacute sclerosing panencephalitis mortality, United States, 1979-2016: Vaccine-induced declines in SSPE deaths.
    Pallivathucal LB; Noymer A
    Vaccine; 2018 Aug; 36(35):5222-5225. PubMed ID: 30057285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.
    Miller C; Farrington CP; Harbert K
    Int J Epidemiol; 1992 Oct; 21(5):998-1006. PubMed ID: 1468866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G
    Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subacute sclerosing panencephalitis (SSPE) in Poland 1987-1989. Stage IV of the epidemiological studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1990; 44(4):265-71. PubMed ID: 2100808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation.
    Schönberger K; Ludwig MS; Wildner M; Weissbrich B
    PLoS One; 2013; 8(7):e68909. PubMed ID: 23874807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Subacute sclerosing panencephalitis (SSPE) in Poland in the years 1993-1995. The sixth stage of epidemiological research].
    Naruszewicz-Lesiuk D; Iwińska-Buksowioz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Przegl Epidemiol; 1997; 51(4):371-80. PubMed ID: 9562784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Epidemiological aspects of SSPE].
    Nihei K
    Nihon Rinsho; 2007 Aug; 65(8):1460-5. PubMed ID: 17695284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subacute sclerosing panencephalitis in children: prevalence in South China.
    Ip P; Chung BH; Wong VC; Chan KY
    Pediatr Neurol; 2004 Jul; 31(1):46-51. PubMed ID: 15246492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors in subacute sclerosing panencephalitis: age- and sex-dependent host reactions or intensive exposure?
    Aaby P; Bukh J; Lisse IM; Smits AJ
    Rev Infect Dis; 1984; 6(2):239-50. PubMed ID: 6374836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and epidemiological characteristics of subacute sclerosing panencephalitis in Bulgaria during the past 25 years (1978-2002).
    Bojinova VS; Dimova PS; Belopitova LD; Mihailov AS; Gatcheva NL; Mihneva ZG; Hristova MT
    Eur J Paediatr Neurol; 2004; 8(2):89-94. PubMed ID: 15253056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute sclerosing panencephalitis surveillance study in Istanbul.
    Onal AE; Gurses C; Direskeneli GS; Yilmaz G; Demirbilek V; Yentur SP; Ozel S; Yapici Z; Tumerdem Y; Gökyigit A
    Brain Dev; 2006 Apr; 28(3):183-9. PubMed ID: 16368215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subacute sclerosing panencephalitis in Southern Africa.
    Mackenzie DJ; Kipps A; McDonald R
    S Afr Med J; 1975 Nov; 49(50):2083-6. PubMed ID: 1198245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further epidemiological investigations on subacute sclerosing panencephalitis (SSPE) in Romania.
    Cernescu C; Milea S
    Virologie; 1980; 31(3):173-82. PubMed ID: 6254241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute sclerosing panencephalitis in The Netherlands--1976-1990.
    Beersma MF; Galama JM; Van Druten HA; Renier WO; Lucas CJ; Kapsenberg JG
    Int J Epidemiol; 1992 Jun; 21(3):583-8. PubMed ID: 1634322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.